Skip to content

Surgical Treatment of Liver Hydatid Cyst (SURGHIDA)

Outcome After Surgical Treatment of Liver Hydatid Cyst

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05420155
Acronym
SURGHIDA
Enrollment
296
Registered
2022-06-15
Start date
2006-01-01
Completion date
2022-05-30
Last updated
2022-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Echinococcosis, Hepatic

Brief summary

The aim was to analyses the incidence and the independent factors associated with Textbook Outcome following surgical treatment of liver hydatid cysts (LHC).

Detailed description

Textbook outcome (TO) is a composite measure to determine the ideal postoperative period and to assess the quality of surgical care. The aim was to analyses the incidence and the independent factors associated with TO following surgical treatment of liver hydatid cysts (LHC). The investigators conducted a retrospective cohort study of patients operated on for hepatic hydatidosis between January 2006 to December 2021. TO occurred when all the following criteria were fulfilled: no mortality within 90 days, no major complications within 90 days, no reintervention within 90 days and no prolonged hospital stay. Univariable and multivariable analyses were performed to identify factors associated with TO.

Interventions

PROCEDURESurgical resection

Surgical treatment of hepatic hydatidic cyst

Sponsors

Complejo Hospitalario Universitario de Badajoz
CollaboratorOTHER
Universidad de Extremadura
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with liver hydatid cyst treated by total or partial pericystectomy

Exclusion criteria

* emergency surgery and simple drainage of cyst

Design outcomes

Primary

MeasureTime frameDescription
Mortality90 daysno mortality within 90 days
Morbidity90 daysno major complications within 90 days
Re-admission90 daysno re-admissions within 90 days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026